KROS
Keros Therapeutics Inc
NASDAQ: KROS · HEALTHCARE · BIOTECHNOLOGY
$11.08
-0.81% today
Updated 2026-09-11
Market cap
$220.28M
P/E ratio
—
P/S ratio
14.67x
EPS (TTM)
$-3.22
Dividend yield
—
52W range
$10 – $23
Volume
0.2M
Keros Therapeutics Inc (KROS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|